Figs Inc vs Smith & Nephew plc — how do they compare? Figs Inc trades at $14.26 (market cap $2.37B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 5.3× Figs Inc's market cap, and Smith & Nephew plc pays a 2.65% dividend while Figs Inc pays none. Which is the better fit depends on your goals.
| FIGS | SNN | |
|---|---|---|
Market Cap | $2.37B | $12.54B |
Sector | Consumer Cyclical | Health |
52-Week High | $17.12 | $38.70 |
52-Week Low | $6.57 | $28.73 |
Enterprise Value | $2.13B | $15.57B |
Dividend Yield | — | 2.65% |
Trailing returns across standard periods
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →